Thalidomide and SU5416 in Treating Patients With Metastatic Melanoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of combining thalidomide and SU5416 in treating
patients who have metastatic melanoma. Thalidomide combined with SU5416 may stop the growth
of metastatic melanoma by stopping blood flow to the tumor.